Mayo Clinic signs five-year R&D deal with Baxter and more digital health deals

By Jonah Comstock
Share

Mayo Clinic announced a five-year research and development collaboration with medical products company Baxter International. Focusing initially on kidney disease, the stated goal of the project is to “advance new technologies and therapies that transform patient care” especially “in areas where breakthrough treatment options can be introduced and innovation can drive access to high-quality care.”

“Baxter is pleased to work with Mayo Clinic, a world-renowned healthcare organization that shares Baxter’s passion for advancing patient-focused innovation,” Baxter CEO José Almeida said in a statement. “The combined power of our two organizations will help us advance new solutions to the most pressing healthcare challenges, further delivering on Baxter’s mission to save and sustain lives.”

In the world of sports tracking, Zebra Sports and Kinduct have teamed up to integrate the Zebra Sports practice system with the Kinduct Athlete Management System. The new system will allow teams to track athletes’ health, wellness, and performance with Zebra and analyze that data with Kinduct’s system.

“Kinduct is a highly secure, cloud-based Athlete Management System that turns rich data into powerful insights that deliver tangible actions that help make coaches, trainers and athletes better,” Dr. Travis McDonough, CEO and founder of Kinduct, said in a statement. “With our collaboration with Zebra, we will provide teams in the NFL and NCAA the right data and the right tools at the right time to help inform the decision-making process, promote constant improvement and provide teams with a competitive advantage.”

Oncology development organization TD2 (Translational Drug Development) has tapped Deep 6 AI for a new partnership to match clinical trials with potential participants in the fields of oncology and fibrosis. 

“Partnering with Deep 6 AI allows TD2 to provide patients with rapid access to the newest, most advanced medicines,” TD2 CEO Stephen Gately said in a statement. “Our sponsor companies benefit from more timely study enrollment and patient identification that precisely matches study protocols, increasing the opportunity to demonstrate clinical activity for new medicines earlier in development.”

The Montreal Heart Institute, Canada’s largest cardiac center, is the latest hospital to use SeamlessMD’s mobile patient engagement and care management system. Notably it’s the first cardiac center in North America to use the technology. More.

The James Cook University Hospital in Middlesborough, part of the UK's National Health Service, has tapped UK-based digital health company Inhealthcare, which offers a remote monitoring platform, to increase understanding of what does and doesn’t work for back pain rehabilitation. More.

Montefiore Health in the Bronx launched a 238 patient pilot with Valera Health, makers of a smartphone app and platform to improve treatment of anxiety and depression. More.

Salt-Lake City-based Intermountain Healthcare has joined American Well’s online care marketplace, best known as “the Exchange.” Through the Exchange, Intermountain will make its nurse practitioners and physician assistants available for patient telehealth visits on Amwell. More.